Compare · INLF vs TMO
INLF vs TMO
Side-by-side comparison of INLIF LIMITED (INLF) and Thermo Fisher Scientific Inc (TMO): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both INLF and TMO operate in Industrial Machinery/Components (Industrials), so they compete in similar markets.
- TMO is the larger of the two at $211.18B, about 958987.2x INLF ($220,209).
- Over the past year, INLF is down 99.9% and TMO is up 17.2% - TMO leads by 117.1 points.
- TMO has been more active in the news (3 items in the past 4 weeks vs 2 for INLF).
- TMO has more recent analyst coverage (25 ratings vs 0 for INLF).
- Company
- INLIF LIMITED
- Thermo Fisher Scientific Inc
- Price
- $3.02-15.41%
- $568.15-0.75%
- Market cap
- $220,209
- $211.18B
- 1M return
- -59.84%
- +15.46%
- 1Y return
- -99.91%
- +17.16%
- Industry
- Industrial Machinery/Components
- Industrial Machinery/Components
- Exchange
- NASDAQ
- NYSE
- IPO
- 2025
- News (4w)
- 2
- 3
- Recent ratings
- 0
- 25
Thermo Fisher Scientific Inc
Thermo Fisher Scientific Inc. offers life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and service worldwide. The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of drugs and vaccines, as well as diagnosis of infections and diseases to pharmaceutical, biotechnology, agricultural, clinical, healthcare, academic, and government markets. Its Analytical Instruments segment provides instruments, consumables, software, and services for use in laboratory, on production line, and in field for pharmaceutical, biotechnology, academic, government, environmental, and other research and industrial markets, as well as clinical laboratories. The company's Specialty Diagnostics segment offers liquid, ready-to-use, and lyophilized immunodiagnostic reagent kits, as well as calibrators, controls, and calibration verification fluids; ImmunoCAP for allergy and asthma tests, and EliA for autoimmunity tests; dehydrated and prepared culture media, collection and transport systems, instrumentation, and consumables; human leukocyte antigen typing and testing for organ transplant market; and healthcare products. Its Laboratory Products and Services segment provides laboratory refrigerators and freezers, ultralow-temperature freezers, and cryopreservation storage tanks; temperature control, sample preparation and preservation, centrifugation, and biological safety cabinet products; water analysis instruments; laboratory plastics products; laboratory chemicals; and pharma services. The company offers products and services through a direct sales force, customer-service professionals, electronic commerce, third-party distributors, and catalogs. It has a strategic alliance with the University of California, San Francisco. The company was incorporated in 1956 and is based in Waltham, Massachusetts.
Latest INLF
- SEC Form 6-K filed by INLIF LIMITED
- SEC Form 6-K filed by INLIF LIMITED
- Large owner Hrt Financial Lp sold $125,517 worth of shares (3,691,666 units at $0.03), decreasing direct ownership by 84% to 726,296 units (SEC Form 4)
- Large owner Hrt Financial Lp bought $186,831 worth of shares (2,919,237 units at $0.06) and sold $218,381 worth of shares (3,831,240 units at $0.06), decreasing direct ownership by 17% to 4,417,962 units (SEC Form 4)
- INLIF LIMITED Announces 1-for-200 Share Combination to Enhance Financial Flexibility and Support Nasdaq Compliance
- Large owner Hrt Financial Lp bought $188,899 worth of shares (4,420,814 units at $0.04), increasing direct ownership by 486% to 5,329,965 units (SEC Form 4)
- New insider Hrt Financial Lp claimed ownership of 1,858,061 shares (SEC Form 3)
- SEC Form 6-K filed by INLIF LIMITED
- INLIF LIMITED Announces Strategic Entry into Humanoid Robotics Market
- INLIF LIMITED Accelerates Strategic Layout in New Energy Sector, Securing $4.4 Million First Order for Battery Cell Packing Machines
Latest TMO
- Thermo Fisher Scientific Inc filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits
- Thermo Fisher Scientific Reports Second Quarter 2026 Results
- Thermo Fisher Scientific Announces Quarterly Dividend
- Thermo Fisher Scientific to Hold Earnings Conference Call on Thursday, July 23, 2026
- SEC Form 4 filed by Director Sperling Scott M
- SEC Form 4 filed by Director Keith R. Alexandra
- SEC Form 4 filed by Director Weisler Dion J
- SEC Form 4 filed by Director Lynch Karen S
- SEC Form 4 filed by Director Johnson Jennifer M
- Bernstein resumed coverage on Thermo Fisher with a new price target